Connect with others who understand.

sign up log in
About MyMyelomaTeam

COVID-19 Vaccine Boosters and Additional Doses for People With Myeloma: Current Guidelines

Posted on October 05, 2021
Medically reviewed by
Todd Gersten, M.D.
Article written by
Alison Channon
Article written by
Aminah Wali, Ph.D.

  • People with multiple myeloma currently may be eligible for a third dose of the Pfizer and Moderna COVID-19 vaccine at least 28 days after their initial two doses.
  • The Centers for Disease Control and Prevention (CDC) also has recommended Pfizer COVID-19 vaccine booster shots for adults over 65 and other high-risk individuals at least six months after their second dose.
  • There is currently no official guidance for additional shots or boosters for those who have received the Johnson & Johnson vaccine.

People with multiple myeloma may be eligible to receive a third dose of the Pfizer or Moderna COVID-19 vaccine shot. Additionally, those who received two doses of the Pfizer vaccine may be eligible for a Pfizer booster shot.

On Aug. 12, the U.S. Food and Drug Administration (FDA) amended the Pfizer and Moderna vaccines’ emergency-use authorizations to allow a third vaccine dose at least 28 days after the second dose for certain immunocompromised individuals. Some immunocompromised people may not develop an adequate immune response after the two-dose COVID-19 vaccination series.

Individuals defined as immunocompromised include:

  • People currently receiving cancer treatment for tumors or blood cancers
  • People who received a stem cell transplant in the last two years
  • People who are organ donor recipients and taking immunosuppressive drugs
  • People taking high-dose steroids or other immunosuppressive drugs, as well as those with certain other health conditions

People with myeloma may qualify as immunocompromised under the above criteria. The CDC recommends individuals consult their doctors to determine if a third dose is appropriate.

There is not yet guidance from the FDA or CDC on additional doses for immunocompromised people who received the Johnson & Johnson vaccine.

Vaccine Booster Shots

If a person with myeloma or a related condition doesn’t qualify for a third vaccine dose at least 28 days after their second Pfizer or Moderna shot, they may be eligible to receive a Pfizer booster shot under new guidelines from the CDC. These boosters are intended for those who received the two-dose series of the Pfizer vaccine but then experienced a drop in immunity over time.

On Sept. 24, the CDC recommended booster shots of the Pfizer COVID-19 vaccine at least six months after a second dose in the following groups:

  • People 65 and older
  • Residents of long-term care facilities
  • People ages 50 to 64 with underlying medical conditions that place them at high risk for severe COVID-19

The CDC recommendations state that people ages 18 to 49 with underlying medical conditions and people ages 18 to 64 who are at risk of COVID-19 exposure due to their work or living arrangements “may receive a booster shot” of the Pfizer vaccine “based on their individual benefits and risks.”

The CDC and FDA have not released booster recommendations about the Moderna vaccine or the single-dose Johnson & Johnson vaccine. Both companies have submitted data on booster shots to the FDA for review.

Do People With Myeloma Need Additional Doses or Boosters?

People with multiple myeloma often have weakened immune systems, due to either low or poorly functioning white blood cell levels caused by the disease itself or a side effect of cancer treatment. This has important implications for how people with myeloma respond to the COVID-19 vaccines, according to Dr. Brian Durie, chairman of the International Myeloma Foundation. “At least half of the patients with myeloma when they get the two-shot Pfizer or Moderna vaccinations, they do not achieve good antibody levels,” he commented in a video released by the foundation.

Antibody levels are an indication of how well a person’s immune system can recognize the coronavirus after getting the vaccine. Lower antibody levels show that people with myeloma are still at a higher risk for severe disease following a standard vaccination schedule.

Dr. Matt Kalaycio, a board-certified hematologist and a professor at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, echoed Dr. Durie’s comments in a conversation with MyMyelomaTeam in September.

The CDC and FDA recommendations for third doses of the Pfizer and Moderna vaccines “are for those patients whose immune systems are compromised — and that would include every single person who has a blood cancer,” Dr. Kalaycio said.

“Everyone with blood cancer is not really fully vaccinated unless they get that third dose,” Dr. Kalaycio added, due to the impact of myeloma on the immune system.

Dr. Kalaycio assured people with myeloma and other blood cancers that both the Pfizer and Moderna COVID-19 vaccines work. “They do create an immune response, but not to the degree that it does in the normal population. So the third dose does seem to bring the immunity up to the level of everybody else,” he said.

Learn More About COVID-19 Vaccines

“We recommend vaccinations for all of our patients with blood cancers, and the only exception to that rule are those who have had stem cell transplants in the last three months,” Dr. Kalaycio stated in his September conversation with MyMyelomaTeam.

Dr. Kalaycio previously answered questions about the COVID-19 vaccines in March. In that conversation, he spoke in greater detail about COVID-19 vaccination and treatments for myeloma, and safety questions about the vaccines.

Talk To Your Doctor

If you have multiple myeloma or a related condition, talk to your doctor about whether you qualify now to receive a third COVID-19 vaccine dose or a booster.

A MyMyelomaTeam Member said:

I was thinking that maybe the booster will put us at a normal level. And Im okay with that . But why they can't fine a cure for this MM .... I just want my life back to normal were I can enjoy working… read more

posted about 1 month ago

hug (5)

Todd Gersten, M.D. is a hematologist-oncologist at the Florida Cancer Specialists & Research Institute in Wellington, Florida. Review provided by VeriMed Healthcare Network. Learn more about him here.
Alison Channon has nearly a decade of experience writing about chronic health conditions, mental health, and women's health. Learn more about her here.
Aminah Wali, Ph.D. received her doctorate in genetics and molecular biology from the University of North Carolina at Chapel Hill. Learn more about her here.

Recent articles

Although multiple myeloma primarily attacks the bones, its effects on bone marrow and the immune...

Symptoms of Multiple Myeloma

Although multiple myeloma primarily attacks the bones, its effects on bone marrow and the immune...
A myeloma diagnosis can significantly impact quality of life. One of the key effects of the...

Nearly Half of MyMyelomaTeam Members Say They Feel Isolated and Alone

A myeloma diagnosis can significantly impact quality of life. One of the key effects of the...
Multiple myeloma is a blood cancer that occurs when one type of white blood cell called a...

Multiple Myeloma Types and Related Conditions

Multiple myeloma is a blood cancer that occurs when one type of white blood cell called a...
Multiple myeloma is diagnosed based on the results of clinical tests. To diagnose myeloma and...

Multiple Myeloma – The Path to Diagnosis

Multiple myeloma is diagnosed based on the results of clinical tests. To diagnose myeloma and...
Multiple myeloma is a type of blood cancer that occurs when lymphocytes (white blood cells)...

Multiple Myeloma – An Overview

Multiple myeloma is a type of blood cancer that occurs when lymphocytes (white blood cells)...
People with multiple myeloma may be eligible for additional doses of the Pfizer and Moderna...

Are People With Myeloma Eligible for Moderna and Johnson & Johnson Booster Shots?

People with multiple myeloma may be eligible for additional doses of the Pfizer and Moderna...
Peripheral neuropathy (PN) — weakness, numbness, or pain related to nerve damage — is a common...

MGUS and Peripheral Neuropathy

Peripheral neuropathy (PN) — weakness, numbness, or pain related to nerve damage — is a common...
Living with multiple myeloma (MM) and undergoing treatments can take a toll on a person’s outlook...

Creating a Positive Outlook While Living With Myeloma

Living with multiple myeloma (MM) and undergoing treatments can take a toll on a person’s outlook...
A variety of tests play a role in diagnosing multiple myeloma, including serum protein...

Understanding Serum Protein Electrophoresis (SPEP) for Multiple Myeloma

A variety of tests play a role in diagnosing multiple myeloma, including serum protein...
Living with myeloma can mean navigating through plenty of unanswered questions involving the...

Fatigue, Bruising, and Telehealth: Dr. Kalaycio Answers Your Top Myeloma Questions

Living with myeloma can mean navigating through plenty of unanswered questions involving the...
MyMyelomaTeam My myeloma Team

Thank you for signing up.

close